Express News | Edwards Lifesciences Corp : Truist Securities Cuts Target Price to $71 From $82
How Is Edwards Lifesciences' Stock Performance Compared to Other Medical Devices Stocks?
Three 'Buys,' Three 'Sells,' and a 'Hold,' by Oppenheimer Analysts
Edwards Lifesciences Price Target Maintained With a $90.00/Share by Oppenheimer
Oppenheimer Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $90
Oppenheimer analyst Suraj Kalia maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 53.2%
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), MoonLake Immunotherapeutics (MLTX) and Protara Therapeutics (TARA)